Nkarta

$48.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.87 (-5.62%) Today
$0.00 (0.00%) As of 9:03 PM UTC after-hours

Why Robinhood?

You can buy or sell Nkarta and other stocks, options, and ETFs commission-free!

About NKTX

Nkarta, Inc. Common Stock, also called Nkarta, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA. The listed name for NKTX is Nkarta, Inc. Common Stock.

CEO
Paul J. Hastings
Employees
—
Headquarters
South San Francisco, California
Founded
2005
Market Cap
1.52B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.69K
High Today
$51.25
Low Today
$47.53
Open Price
$51.25
Volume
124.06K
52 Week High
$79.16
52 Week Low
$22.46

Collections

NKTX Earnings

-$6.08
-$4.05
-$2.03
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 15, After Hours

You May Also Like

VS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure